171 related articles for article (PubMed ID: 36845294)
21. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
22. Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Deng MY; Hinz F; Maas SLN; Anil G; Sievers P; Conde-Lopez C; Lischalk J; Rauh S; Eichkorn T; Regnery S; Bauer L; Held T; Meixner E; Lang K; Hörner-Rieber J; Herfarth K; Jones D; Pfister SM; Jungk C; Unterberg A; Wick W; von Deimling A; Debus J; Sahm F; König L
Neurooncol Adv; 2023; 5(1):vdad059. PubMed ID: 37293256
[TBL] [Abstract][Full Text] [Related]
23. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
24. Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas.
Kim MS; Kim KH; Lee EH; Lee YM; Lee SH; Kim HD; Kim YZ
J Neurosurg; 2014 Nov; 121(5):1189-200. PubMed ID: 25148008
[TBL] [Abstract][Full Text] [Related]
25. Utility of Neuronavigation in Intracranial Meningioma Resection: A Single-Center Retrospective Study.
Bir SC; Konar SK; Maiti TK; Thakur JD; Guthikonda B; Nanda A
World Neurosurg; 2016 Jun; 90():546-555.e1. PubMed ID: 26805681
[TBL] [Abstract][Full Text] [Related]
26. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
27. The role of radiotherapy following gross-total resection of atypical meningiomas.
Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the Surgical Outcome of Pterional and Frontotemporal-Orbitozygomatic Approaches and Determination of Predictors of Recurrence for Sphenoid Wing Meningiomas.
Bir SC; Maiti T; Konar S; Nanda A
World Neurosurg; 2017 Mar; 99():308-319. PubMed ID: 27771478
[TBL] [Abstract][Full Text] [Related]
29. Loss of H3K27me3 in meningiomas.
Nassiri F; Wang JZ; Singh O; Karimi S; Dalcourt T; Ijad N; Pirouzmand N; Ng HK; Saladino A; Pollo B; Dimeco F; Yip S; Gao A; Aldape KD; Zadeh G;
Neuro Oncol; 2021 Aug; 23(8):1282-1291. PubMed ID: 33970242
[TBL] [Abstract][Full Text] [Related]
30. The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma.
Jung M; Kim SI; Lim KY; Bae J; Park CK; Choi SH; Park SH; Won JK
Hum Pathol; 2021 Sep; 115():96-103. PubMed ID: 34186055
[TBL] [Abstract][Full Text] [Related]
31. Evaluating risk of recurrence in patients with meningioma.
Traylor JI; Plitt AR; Hicks WH; Mian TM; Mickey BE; Barnett SL
J Neurosurg; 2023 Mar; 138(3):621-628. PubMed ID: 36866795
[TBL] [Abstract][Full Text] [Related]
32. Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence.
Katz LM; Hielscher T; Liechty B; Silverman J; Zagzag D; Sen R; Wu P; Golfinos JG; Reuss D; Neidert MC; Wirsching HG; Baumgarten P; Herold-Mende C; Wick W; Harter PN; Weller M; von Deimling A; Snuderl M; Sen C; Sahm F
Acta Neuropathol; 2018 Jun; 135(6):955-963. PubMed ID: 29627952
[TBL] [Abstract][Full Text] [Related]
33. Benign versus atypical meningiomas: risk factors predicting recurrence.
Nowak A; Dziedzic T; Krych P; Czernicki T; Kunert P; Marchel A
Neurol Neurochir Pol; 2015; 49(1):1-10. PubMed ID: 25666766
[TBL] [Abstract][Full Text] [Related]
34. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
Oya S; Kawai K; Nakatomi H; Saito N
J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
[TBL] [Abstract][Full Text] [Related]
35. Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence.
Zhang H; Ma L; Wang YB; Shu C; Kuang W; Huang YA; Dong LQ; Cheng GG
World Neurosurg; 2017 Jan; 97():693-700.e11. PubMed ID: 27744084
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
[TBL] [Abstract][Full Text] [Related]
37. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.
Marciscano AE; Stemmer-Rachamimov AO; Niemierko A; Larvie M; Curry WT; Barker FG; Martuza RL; McGuone D; Oh KS; Loeffler JS; Shih HA
J Neurosurg; 2016 Jan; 124(1):106-14. PubMed ID: 26274991
[TBL] [Abstract][Full Text] [Related]
38. Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma.
Nguyen MP; Morshed RA; Dalle Ore CL; Cummins DD; Saggi S; Chen WC; Choudhury A; Ravi A; Raleigh DR; Magill ST; McDermott MW; Theodosopoulos PV
J Neurosurg; 2023 Jan; 138(1):86-94. PubMed ID: 36303473
[TBL] [Abstract][Full Text] [Related]
39. Outcome of resection of WHO Grade II meningioma and correlation of pathological and radiological predictive factors for recurrence.
Nanda A; Bir SC; Konar S; Maiti T; Kalakoti P; Jacobsohn JA; Guthikonda B
J Clin Neurosci; 2016 Sep; 31():112-21. PubMed ID: 27427214
[TBL] [Abstract][Full Text] [Related]
40. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection.
Hardesty DA; Wolf AB; Brachman DG; McBride HL; Youssef E; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2013 Aug; 119(2):475-81. PubMed ID: 23394332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
